Pannell L

Lewis Pannell, Ph.D.

Head, Proteomics and Mass Spectrometry LaboratoryProfessor of Oncologic Sciences, Biochemistry and Molecular BiologySpecialty: Cancer CareEmail Researcher

About Lewis Pannell

Dr. Lewis Pannell, who received his Ph.D. in Chemistry from the University of Canterbury, Christchurch, New Zealand, is head of the Proteomics and Mass Spectrometry Laboratory at the Mitchell Cancer Institute (MCI). Previously, Dr. Pannell served as senior investigator with the National Institutes of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD. His research team currently focuses on several areas of research including improving the early detection of late stage cancers such as pancreatic cancer, determining new biomarkers for gynecological cancers, developing new screening methods for non-cancer related issues such as pregnancy complications, and improving methods for the testing of prostate cancer.

Research Interests

  • Identifying proteomic biomarkers using proteomic and glycomic methods for the early detection and monitoring of cancer
  • Special interest in cancers that are diagnosed late stage such as ovarian and pancreatic cancer
  • Developing new screening methods for issues such as complications of pregnancy
  • Methods to improve the prostate cancer testing


  • Postgraduate: Chemistry, University of Canterbury | Christchurch, New Zealand

Research Location

USA Health has a comprehensive biomedical research program that spans a wide range of clinical, basic and translational research.​ At the Mitchell Cancer Institute, our physicians and scientific investigators are searching for breakthrough discoveries to improve the lives of cancer patients.

This link will open in a new tab or window.